Table 1.
Patient characteristics
| All patients (n = 50) | Child A (n = 14) | Child B (n = 15) | Child C (n = 21) | P-value | |
|---|---|---|---|---|---|
| Age (years) | 52 (45–57) | 51 (45–57) | 52 (42–55) | 56 (48–60) | 0.23 |
| Sex M/F | 46/4 | 14/0 | 13/2 | 19/2 | 0.39 |
| BMI | 26 (24–29) | 27 (23–29) | 26 (23–26) | 26 (24–29) | 0.35 |
| MELD | 13 (11–17) | 10 (9–11)* | 16 (12–17) | 17 (13–19) | < 0.001 |
| Graft weight (g) | 835 (660–950) | 865 (615–1022) | 690 (620–800)† | 870 (740–990) | 0.012 |
| Intraoperative use of vasopressor | 20 (40%) | 0 | 2 (13%) | 18 (86%)* | < 0.001 |
| Intraoperative use of colloid (ml) | 2000 (1000) | 1500 (500) | 1700 (650) | 2000 (900) | 0.14 |
| ICU stay (days) | 7 (7–10) | 7 (7–10) | 7 (7–14) | 7 (7–10) | 0.9 |
| Hospital stay (days) | 21 (21–21) | 21 (21–22) | 21 (21–30) | 21 (21–21) | 0.78 |
Data are presented as median (IQR) or ratio
BMI body mass index, MELD Model for end-stage liver disease, ICU intensive care unit
adenotes significant compared to the other two groups. bdenotes significant compared to CHILD C. p < 0.05